Alector

AbbVie dumps Alector's Alzheimer's immunotherapy after phase 1 review
Fierce Biotech
Fri, 07/8/22 - 10:43 am
Alector
AbbVie
Alzheimer's disease
clinical trials
AL003
Opportunities arise for once-spurned partners
EP Vantage
Fri, 05/13/22 - 10:34 am
Pfizer
Biohaven
licensing
M&A
Aurinia
Bristol Myers Squibb
AbbVie
Alector
Arcus Biosciences
Biogen
Blueprint Medicines
CureVac
Gilead Sciences
GSK
Incyte
MorphoSys
Roche
Nestle
SAGE Therapeutics
Sarepta Therapeutics
Seres Therapeutics
Syndax
Licensing deals rack up in 2021
EP Vantage
Fri, 12/10/21 - 10:46 am
licensing
GSK
Alector
Novartis
BeiGene
Pfizer
Arvinas
iTeos Therapeutics
Bristol Myers Squibb
Eisai
GSK, under pressure to perform, pens $2.2B deal with Alector focused on neuro R&D, Alzheimer's
Fierce Biotech
Fri, 07/2/21 - 11:00 am
GSK
biobucks
Alector
neurodegenerative disease
Alzheimer's disease
A Look at 5 Big and Interesting Biotech IPOs for 2019
BioSpace
Fri, 12/20/19 - 12:36 pm
IPOs
NASDAQ
Adaptive Biotechnologies
Genmab
Gossamer Bio
BridgeBio
Alector
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
Mon, 12/2/19 - 09:42 am
ASH2019
Roche
Bristol-Myers Squibb
Acadia Pharmaceuticals
Biogen
Cassava Sciences
Alector
GW Pharma
Magenta Therapeutics
Fortress Biotech
Mustang Bio
Bluebird Bio
Alector, Prevail trade blows over alleged misuse of confidential information
Fierce Biotech
Fri, 08/16/19 - 10:12 am
Alector
Prevail Therapeutics
trade secrets
BioSpace's List of February 2019 Life Science IPOs
BioSpace
Mon, 02/11/19 - 08:22 pm
IPOs
Shockwave Medical
Harpoon Therapeutics
Gossamer Bio
Alector
Hoth Therapeutics
Alector IPO Banks $176M to Test Alzheimer’s Drugs in Clinical Trials
Xconomy
Wed, 02/6/19 - 10:34 pm
Alector
IPOs
Alzheimer's disease
Immuno-Neurology Focused Alector Files $180 Million IPO
CP Wire
Tue, 01/29/19 - 03:43 pm
Alector
IPOs
immuno-neurology
Immuno-Neurology Focused Alector Files $180 Million IPO
Tue, 01/29/19 - 03:42 pm
Alector
Alector Files for IPO to Fund Studies of Alzheimer’s, Dementia Drugs
Xconomy
Tue, 01/8/19 - 09:19 am
IPOs
Alector
Alzheimer's disease
dementia
Four Healthcare Startups Raised Over $130 Million Last Month
Forbes
Tue, 08/7/18 - 11:46 pm
startups
23andMe
Gossamer Bio
Alector
Compass Therapeutics
AbbVie antes up $225M in cash to buy into the Alzheimer’s platform at Alector
Endpoints
Tue, 10/24/17 - 09:10 am
AbbVie
Alzheimer's disease
Alector
R&D
The 2015 Fierce 15 biotech execs take a bow
Fierce Biotech
Sat, 10/3/15 - 02:01 pm
Alector
Arvinas
CRISPR Therapeutics
Intellia Therapeutics
NGM Biopharmaceuticals
Padlock Therapeutics
SQZ Biotech
Revolution Medicines
Syros Pharmaceuticals
Unum Therapeutics
Yumanity Therapeutics
FierceBiotech's 2015 Fierce 15
Fierce Biotech
Wed, 09/30/15 - 09:51 am
Alector
Arvinas
Cell Medica
CRISPR Therapeutics
Denali Therapeutics
Intellia Therapeutics
MyoKardia
NGM Biopharmaceuticals
Padlock Therapeutics
Revolution Medicines SQZ Biotech
Surface Oncology
Syros Pharmaceuticals
Unum Therapeutics
Yumanity Therapeutics
J&J partners with a biotech start-up on a new approach to Alzheimer's
Fierce Biotech
Mon, 03/10/14 - 10:19 am
JNJ
Alzheimer's disease
Alector